Oral supplementation with a probiotic containing Lactobacillus reuteri alone was sufficient to inhibit BC tumorigenesis in murine models genetically predisposed to neoplasia and fed a cancer-promoting western diet through microbially-initiated CD4+/CD25+ lymphocytes (225). This evidence concerns the gene CD4 and neoplasm.